VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
VVERX
Price
$8.88
Change
+$0.04 (+0.45%)
Updated
Jul 31 closing price
Net Assets
110.9M
Interact to see
Advertisement

VSCIX vs VVERX

VSCIX vs VVERX Comparison Chart in %
View a ticker or compare two or three
VS
VSCIX vs. VVERX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCIX is a Hold and VVERX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. VVERX (111M). VSCIX pays higher dividends than VVERX: VSCIX (1.23) vs VVERX (1.12). VSCIX was incepted earlier than VVERX: VSCIX (29 years) vs VVERX (7 years). VVERX (1.04) is less costly to investors than VSCIX (0.03). VVERX is a more actively managed with annual turnover of: 77.00 vs. VSCIX (17.00). VVERX has a lower initial minimum investment than VSCIX: VVERX (2500000) vs VSCIX (5000000). VVERX annual gain was more profitable for investors over the last year : 27.77 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. VVERX (-16.78).
VSCIXVVERXVSCIX / VVERX
Total Expense Ratio0.030.774%
Annual Report Gross Expense Ratio0.031.043%
Fund Existence29 years7 years-
Gain YTD14.59119.62874%
Front LoadN/AN/A-
Min. Initial Investment50000002500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets189B111M170,270%
Annual Yield % from dividends1.231.12109%
Returns for 1 year22.5827.7781%
Returns for 3 years43.4410.40418%
Returns for 5 years35.13-16.78-209%
Returns for 10 years156.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C